Abstract | AIM: To evaluate the long-term histological outcome of patients transplanted for HBV-related liver disease and given HBIg prophylaxis indefinitely after LT. METHODS: Forty-two consecutive patients transplanted for hepatitis B were prospectively studied. HBsAg, HBV- DNA and liver function tests were evaluated in the serum 3, 6 and 12 mo after LT and then yearly. LB was obtained 6 and 12 mo after LT and yearly thereafter. Chronic hepatitis (CH) B after LT was classified as minimal, mild, moderate or severe. RESULTS: HBV recurred in 7/42 (16.6%) patients after 6-96 mo of follow-up. A hundred and eighty-seven LB were evaluated. Four of 7 patients with graft reinfection, all with unknown HBV DNA status before LT, developed cirrhosis at 12-36 mo of follow-up. Of the 122 LB obtained from 28 HBsAg+/HCV- recipients with no HBV recurrence after LT, all biopsies were completely normal in only 2 patients (7.1%), minimal/non-specific changes were observed in 18 (64.2%), and at least 1 biopsy showed CH in the remaining 8 (28.5%). Twenty-nine LB obtained from 7 patients transplanted for HBV-HCV cirrhosis and remaining HBsAg- after LT revealed recurrent CH-C. Actuarial survival was similar in patients with HBsAg+ or HBsAg- liver diseases. CONCLUSION: Though protocol biopsies may enable the detection of graft dysfunction at an early stage, the risk of progression and the clinical significance of these findings remains to be determined.
|
Authors | Stefano Targhetta, Federico Villamil, Paolo Inturri, Patrizia Pontisso, Stefano Fagiuoli, Umberto Cillo, Attilio Cecchetto, Simona Gianni, Remo Naccarato, Patrizia Burra |
Journal | World journal of gastroenterology
(World J Gastroenterol)
Vol. 12
Issue 11
Pg. 1706-12
(Mar 21 2006)
ISSN: 1007-9327 [Print] United States |
PMID | 16586538
(Publication Type: Evaluation Study, Journal Article)
|
Chemical References |
- DNA, Viral
- Hepatitis B Surface Antigens
- Immunoglobulins
- hepatitis B hyperimmune globulin
|
Topics |
- Biopsy, Needle
(methods)
- Clinical Protocols
- DNA, Viral
(blood)
- Follow-Up Studies
- Hepatitis B
(diagnosis, surgery)
- Hepatitis B Surface Antigens
(blood)
- Hepatitis B virus
(genetics)
- Humans
- Immunoglobulins
(therapeutic use)
- Liver
(pathology)
- Liver Cirrhosis
(diagnosis)
- Liver Function Tests
- Liver Transplantation
(pathology)
- Prospective Studies
- Recurrence
- Time Factors
- Treatment Outcome
|